Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 6 studies | 23% ± 6% | |
peripheral blood | 5 studies | 28% ± 13% | |
intestine | 5 studies | 25% ± 7% | |
brain | 5 studies | 25% ± 7% | |
eye | 5 studies | 29% ± 10% | |
liver | 4 studies | 23% ± 2% | |
kidney | 3 studies | 17% ± 1% | |
uterus | 3 studies | 39% ± 10% | |
breast | 3 studies | 31% ± 14% | |
adipose | 3 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 5123.86 | 21 / 21 | 100% | 62.14 | 504 / 504 |
intestine | 100% | 4814.28 | 966 / 966 | 100% | 57.53 | 527 / 527 |
pancreas | 100% | 3506.60 | 328 / 328 | 100% | 52.82 | 178 / 178 |
prostate | 100% | 5481.50 | 245 / 245 | 100% | 75.63 | 502 / 502 |
stomach | 100% | 4434.25 | 359 / 359 | 100% | 54.43 | 286 / 286 |
thymus | 100% | 5706.60 | 653 / 653 | 100% | 71.04 | 605 / 605 |
uterus | 100% | 5099.59 | 170 / 170 | 100% | 64.68 | 459 / 459 |
breast | 100% | 3832.10 | 459 / 459 | 100% | 68.20 | 1117 / 1118 |
skin | 100% | 4506.99 | 1807 / 1809 | 100% | 73.36 | 472 / 472 |
liver | 100% | 3838.96 | 226 / 226 | 100% | 49.85 | 405 / 406 |
kidney | 100% | 3892.55 | 89 / 89 | 100% | 57.43 | 898 / 901 |
brain | 100% | 3283.26 | 2633 / 2642 | 100% | 81.82 | 705 / 705 |
adrenal gland | 100% | 5808.78 | 258 / 258 | 100% | 55.74 | 229 / 230 |
ovary | 100% | 5033.46 | 180 / 180 | 100% | 44.49 | 428 / 430 |
lung | 99% | 4135.96 | 575 / 578 | 100% | 56.96 | 1154 / 1155 |
esophagus | 100% | 4389.30 | 1440 / 1445 | 99% | 63.10 | 182 / 183 |
eye | 0% | 0 | 0 / 0 | 100% | 45.92 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 59.50 | 29 / 29 |
spleen | 100% | 5644.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 58.85 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 111.54 | 1 / 1 |
blood vessel | 100% | 4171.46 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 4134.50 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 3050.81 | 784 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1983.00 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 3832.69 | 893 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
GO_0032206 | Biological process | positive regulation of telomere maintenance |
GO_1904290 | Biological process | negative regulation of mitotic DNA damage checkpoint |
GO_0006606 | Biological process | protein import into nucleus |
GO_0072357 | Cellular component | PTW/PP1 phosphatase complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0004864 | Molecular function | protein phosphatase inhibitor activity |
GO_0003677 | Molecular function | DNA binding |
GO_0008157 | Molecular function | protein phosphatase 1 binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | PPP1R10 |
Protein name | Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) (PP1-binding protein of 114 kDa) (Phosphatase 1 nuclear targeting subunit) (Protein FB19) (p99) Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) PPP1R10 protein |
Synonyms | CAT53 hCG_26006 PNUTS FB19 |
Description | FUNCTION: Scaffold protein which mediates the formation of the PTW/PP1 phosphatase complex by providing a binding platform to each component of the complex. The PTW/PP1 phosphatase complex plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Mediates interaction of WDR82 and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA, single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers (By similarity). . FUNCTION: Scaffold protein which mediates the formation of the PTW/PP1 phosphatase complex by providing a binding platform to each component of the complex. The PTW/PP1 phosphatase complex plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Mediates interaction of WDR82 and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA, single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers. . |
Accessions | ENST00000420949.6 ENST00000376511.7 ENST00000429597.6 ENST00000426299.6 Q2L6I0 Q58F28 ENST00000383586.8 ENST00000449113.6 Q96QC0 ENST00000424446.6 |